• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE; STENT, SUPERFICIAL FEMORAL ARTERY Back to Search Results
Catalog Number PAHR080502E
Device Problems Patient-Device Incompatibility (2682); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Aneurysm (1708)
Event Date 08/24/2021
Event Type  Injury  
Manufacturer Narrative
In total four (4) medwatch reports related to this event are being submitted.All reports refer to the same patient identifier.The manufacturer report numbers are not available at the time of submission.Cbas¿ heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Event Description
On (b)(6) 2020, the patient underwent an endovascular branched endovascular aortic repair (bevar) with a customized fenestrated/ branched stent graft component (cook medical) because of a thoracoabdominal aneurysm type iv.The following branches were treated with one gore¿ viabahn¿ vbx balloon expandable endoprosthesis (viabahn¿ vbx device) each: celiac artery, left renal artery, right renal artery, and superior mesenteric artery.A gore¿ viabahn¿ endoprosthesis with propaten bioactive surface (viabahn¿ device) was used to extend the viabahn¿ vbx device implanted in the superior mesenteric artery distally.Access was gained via a cut down to the axillary artery to implant the viabahn¿ vbx devices and the viabahn¿ device.Reportedly, the procedure was very complex because of the anatomy.A very small endoleak occurred at the ostium of the left renal artery which was resolved during the procedure.They suspected that a pre-existing large calcification at the ostium of the left renal artery may have contributed to this small endoleak.On (b)(6) 2021, the patient was diagnosed a type 2 endoleak related to the customized fenestrated/ branched stent graft component (cook medical), a type 3 endoleak from the left renal artery branch, a type 1c endoleak from the superior mesenteric artery branch, and a stenosis (50 %) of the celiac trunk branch.Reportedly, they suspected that these complications may be related to the complex procedure and the pre-existing large calcification.Reportedly, they do not suspect the complications to be caused by the implanted devices.They noted that this anatomical location is also stressed by respiratory motion which may have favored the formation of the endoleaks and the stenosis of the celiac trunk.On (b)(6) 2021, an endovascular reintervention was performed to resolve the endoleaks and the stenosis successfully.It was stated that the event was resolved without sequelae.
 
Manufacturer Narrative
H6-code 213: a review of the manufacturing records indicated the device met pre-release specifications.H6-code 4111: requests were emailed to the physician to provide dicom images (pre, peri/intra, post) for evaluation.The requests remained unanswered.Therefore an imaging evaluation could not be performed.With no additional information provided, gore is unable to perform further investigations of this event.Four (4) devices are involved in this event.Therefore, in total four (4) medwatch reports have been submitted: manufacturer report number 2017233-2021-02419.Manufacturer report number 2017233-2021-02416.Manufacturer report number 2017233-2021-02417.Manufacturer report number 2017233-2021-02418.
 
Manufacturer Narrative
H6-code 4111: the user reported that they suspect the complications to be related to the complex procedure and anatomy and not caused by the implanted devices.Dicom images (pre, peri/intra, post) have been requested from the physician for evaluation.The requests remained unanswered.With no additional information provided gore was unable to perform further investigation of this incident.The cause of the endoleak could not be confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® ENDOPROSTHESIS WITH HEPARIN BIOACTIVE SURFACE
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
sibylle staerk
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12553183
MDR Text Key274037019
Report Number2017233-2021-02417
Device Sequence Number1
Product Code NIP
Combination Product (y/n)Y
Reporter Country CodeGM
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 12/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/30/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/20/2022
Device Catalogue NumberPAHR080502E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received12/02/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured12/21/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age80 YR
Patient SexMale
Patient Weight86 KG
-
-